P041. Systematic review of surgical and patient reported outcomes of neoadjuvant endocrine therapy for breast cancer
P041. Systematic review of surgical and patient reported outcomes of neoadjuvant endocrine therapy for breast cancer
Introduction: neoadjuvant endocrine therapy (NET) represents a treatment option for downstaging in postmenopausal women with ER-positive early breast cancer. It is available where chemotherapy is not indicated or not judged to be of benefit, and NET produces equivalent clinical and radiological responses to neoadjuvant chemotherapy but with lower toxicity. However, comparison of NET to standard of care surgery first followed by adjuvant therapy is less clear, particularly in relation to surgical outcomes including breast-conservation, re-excision and positive margin rates, quality of life (QoL) and recurrence.
Methods: a systematic review following PRISMA guidelines to evaluate the effect of NET on surgical outcomes QoL and recurrence (Prospero registration ID: CRD42020209257). We searched PubMed and EMBASE to identify clinical trial and cohort studies between 1946 to 05/10/2020. Identified records were manually screened by title, abstract and full-text review by two independent reviewers. Data extraction will be conducted using a pre-piloted data collection tool. Risk of bias will be assessed using Cochrane Collaboration tools.
Results: the search identified 2368 articles. After removing duplicates, 1610 articles were eligible for title screening. Title screening resulted in 323 articles eligible for abstract screening and 35 eligible for full-text review. Eight papers were identified by reference checking, and in total 23 papers were eligible for final review. Data extraction and evidence synthesis is currently in progress.
Conclusion: understanding surgical and patient-reported outcomes with NET may impact surgical practice. The evaluation of current evidence will also inform future trials assessing the impact of NET on surgical outcomes and QoL.
e306-e307
Brett, Beatrice
0b153cf1-6fcc-48e3-8498-e36c059d7420
Savva, Constantinos
33110108-fcc0-463a-8532-ef32e1e084ce
Davies, Lucy
a8345f27-4388-40bb-964e-c43c89c3bf1b
Douek, Michael
459e9a01-c7a6-4f6a-bc26-44247b0e9b3f
Copson, Ellen
a94cdbd6-f6e2-429d-a7c0-462c7da0e92b
Cutress, Ramsey
68ae4f86-e8cf-411f-a335-cdba51797406
4 May 2021
Brett, Beatrice
0b153cf1-6fcc-48e3-8498-e36c059d7420
Savva, Constantinos
33110108-fcc0-463a-8532-ef32e1e084ce
Davies, Lucy
a8345f27-4388-40bb-964e-c43c89c3bf1b
Douek, Michael
459e9a01-c7a6-4f6a-bc26-44247b0e9b3f
Copson, Ellen
a94cdbd6-f6e2-429d-a7c0-462c7da0e92b
Cutress, Ramsey
68ae4f86-e8cf-411f-a335-cdba51797406
Brett, Beatrice, Savva, Constantinos, Davies, Lucy, Douek, Michael, Copson, Ellen and Cutress, Ramsey
(2021)
P041. Systematic review of surgical and patient reported outcomes of neoadjuvant endocrine therapy for breast cancer.
European Journal of Surgical Oncology, 47 (5), .
(doi:10.1016/j.ejso.2021.03.045).
Record type:
Meeting abstract
Abstract
Introduction: neoadjuvant endocrine therapy (NET) represents a treatment option for downstaging in postmenopausal women with ER-positive early breast cancer. It is available where chemotherapy is not indicated or not judged to be of benefit, and NET produces equivalent clinical and radiological responses to neoadjuvant chemotherapy but with lower toxicity. However, comparison of NET to standard of care surgery first followed by adjuvant therapy is less clear, particularly in relation to surgical outcomes including breast-conservation, re-excision and positive margin rates, quality of life (QoL) and recurrence.
Methods: a systematic review following PRISMA guidelines to evaluate the effect of NET on surgical outcomes QoL and recurrence (Prospero registration ID: CRD42020209257). We searched PubMed and EMBASE to identify clinical trial and cohort studies between 1946 to 05/10/2020. Identified records were manually screened by title, abstract and full-text review by two independent reviewers. Data extraction will be conducted using a pre-piloted data collection tool. Risk of bias will be assessed using Cochrane Collaboration tools.
Results: the search identified 2368 articles. After removing duplicates, 1610 articles were eligible for title screening. Title screening resulted in 323 articles eligible for abstract screening and 35 eligible for full-text review. Eight papers were identified by reference checking, and in total 23 papers were eligible for final review. Data extraction and evidence synthesis is currently in progress.
Conclusion: understanding surgical and patient-reported outcomes with NET may impact surgical practice. The evaluation of current evidence will also inform future trials assessing the impact of NET on surgical outcomes and QoL.
This record has no associated files available for download.
More information
Published date: 4 May 2021
Identifiers
Local EPrints ID: 472616
URI: http://eprints.soton.ac.uk/id/eprint/472616
ISSN: 0748-7983
PURE UUID: ba849dd9-76d4-44ce-80a5-6af25d4bc941
Catalogue record
Date deposited: 12 Dec 2022 17:42
Last modified: 16 Mar 2024 23:14
Export record
Altmetrics
Contributors
Author:
Beatrice Brett
Author:
Constantinos Savva
Author:
Lucy Davies
Author:
Michael Douek
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics